flumazenil has been researched along with Ataxia Telangiectasia Syndrome in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carranza, D | 1 |
| Vega, AK | 1 |
| Torres-Rusillo, S | 1 |
| Montero, E | 1 |
| Martinez, LJ | 1 |
| Santamaría, M | 1 |
| Santos, JL | 1 |
| Molina, IJ | 1 |
1 other study available for flumazenil and Ataxia Telangiectasia Syndrome
| Article | Year |
|---|---|
Molecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-Telangiectasia.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Base Sequence; Cell Line; Codon, Nons | 2017 |